1. China Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: major
Cachet Pharmaceutical Co., Ltd. Class A

Cachet Pharmaceutical Co., Ltd. Class A

SSZSE:002462
11.61
CNY
+0.11
(+0.96%)
0.38EPS
26.57P/E
3.13BMarket Cap
Cachet Pharmaceutical Co., Ltd. Class A
SZSE:002462
(Shenzhen Stock Exchange)

Recent

price

11.61

P/E

ratio

26.57

div

yld

0.53%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
6.63
7.64
10.58
14.7
23.21
34.13
43.77
56.71
71.81
84.98
79.82
87.62
90.07
103.16
82.02
66.62
62.9
Revenue per Share
0.24
0.27
0.27
0.54
0.95
0.72
0.89
1.05
1.31
1.44
1.09
1.21
1.02
0.86
0.54
0.38
0.4
Basic EPS, GAAP
-0.57
-0.18
-0.42
-1.39
-3.41
-1.57
0.31
-1.57
-1.25
0.12
2.94
2.28
-1.21
4.8
0.56
4.67
- -
Free Cash Flow per Basic Share
0.08
0.15
0.15
0.14
0.45
0.44
0.52
0.48
0.89
0.96
0.99
0.83
0.97
0.74
0.57
0.37
0.06
Dividend per Share
4.26
4.41
4.56
4.94
5.36
5.96
7.91
8.81
9.97
11.74
12.44
13.32
13.98
14.54
14.71
14.92
15.22
Book Value per Share
4.04
4.27
4.42
4.39
3.31
3.82
5.86
6.05
7.23
9.41
10.36
11.27
12.09
12.78
13.27
13.64
13.94
Tangible Book Value per Share
202
236
242
241
240
240
251
251
250
261
291
292
291
291
293
293
292
Basic Weighted Avg Shares
1,342
1,801
2,554
3,544
5,572
8,200
10,972
14,239
17,960
22,187
23,256
25,626
26,220
29,996
24,019
19,525
18,366
Sales/Revenue/Turnover
4.76
3.34
3.42
3.99
5.64
5.98
5.78
5.21
5.45
5.02
5.16
4.05
3.61
3.02
2.84
3.67
3.51
Operating Margin (%)
9
8
13
17
22
25
28
30
32
81
176
201
227
202
127
87
- -
Depreciation Expense
49
64
65
130
228
173
223
264
328
376
318
354
297
250
158
111
118
Net Income, GAAP
24.52
25.26
24.75
24.52
25.36
25.23
25.76
25.38
26.36
25.66
27.43
26.95
27.38
32.19
42.07
63.43
61.43
Effective Tax Rate (%)
3.62
3.54
2.55
3.67
4.09
2.11
2.03
1.85
1.82
1.69
1.37
1.38
1.13
0.83
0.66
0.57
0.64
Profit Margin (%)
627
651
626
719
741
1,197
1,917
2,759
3,317
3,572
3,971
4,263
4,581
4,781
5,091
5,068
5,178
Working Capital
- -
- -
- -
- -
- -
- -
6
746
746
193
176
229
209
176
130
104
94
LT Debt
1,025
1,090
1,128
1,303
1,675
2,202
2,935
3,197
3,733
4,923
5,324
5,657
5,922
6,092
5,993
5,876
5,964
Total Equity
5.92
4.92
6.18
9.66
14.55
9.24
9.68
8.82
8.72
8.43
6.76
6.5
4.8
3.78
3.57
1.31
1.31
Return on Invested Capital (%)
6
6.01
5.53
9.04
8.34
3.21
2.31
2.63
3.44
2.99
1.98
2.41
2.64
2.33
0.79
1.83
1.51
Return on Capital (%)
6.13
6.12
6.06
11.41
18.44
12.73
13.08
12.59
13.93
12.7
9
9.42
7.46
6.01
3.71
2.58
2.68
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
1,737
1,698
1,455
LT Borrowings
- -
- -
- -
LT Finance Leases
104
96
94
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
292
292
292
Market Capitalization
4,189
4,201
3,130

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
11,835
11,044
10,735
Cash, Cash Equivalents & STI
2,564
2,281
2,621
Accounts Receivable, Net
5,890
5,602
5,444
Inventories
2,465
2,478
2,102
Total Current Liabilities
6,767
5,927
5,557
Payables & Accruals
- -
- -
- -
ST Debt
1,737
1,698
1,455
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
10.92%
2.05%
-1.96%
Free Cash Flow
181.08%
-5.93%
730.29%
Net Income, GAAP
-1.61%
-17.36%
-29.57%
Sales/Revenue/Turnover
10.63%
-2.35%
-18.71%
Total Cash Common Dividend
4.79%
-16.13%
-35.03%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
7,443
5,396
5,651
5,529
24,019
2025
4,678
5,021
- -
5,067
19,525
2026
3,972
4,306
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.26
0.32
0.22
-0.25
0.54
2025
0.16
0.21
- -
-0.1
0.38
2026
0.13
0.17
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.11
0.33
0.19
-0.06
0.57
2025
0.12
0.2
- -
-0.2
0.37
2026
0.02
0.04
- -
- -
- -
Similar Companies
Eli Lilly and Company (NYSE:LLY)
Novo Nordisk A/S (NYSE:NVO)
Johnson & Johnson (NYSE:JNJ)
Pfizer, Inc. (NYSE:PFE)
Dr. Reddy's Laboratories Ltd. (NSE:DRREDDY)
Divi's Laboratories Limited (NSE:DIVISLAB)
Business
Cachet Pharmaceutical Co., Ltd. Cachet Pharmaceutical Co., Ltd. (002462.SZ) is a China-based company primarily engaged in pharmaceutical wholesale, retail, and distribution. The company provides pharmaceutical sales including biochemical drugs and traditional Chinese medicines; medical equipment and device sales; pharmaceutical logistics and chain retail services; and health care products. Founded in 1997 and headquartered in Beijing, it operates principally within China and listed on the Shenzhen Stock Exchange in 2010, entering the China Everbright Group China Everbright Limited system in 2018 as the main platform for its health business sector. In recent developments, the company approved a final cash dividend on A shares for the year 2024, payable on 30 June 2025, reflecting ongoing financial stability amid its focus on innovation, technology-driven reforms, and expansion in drug and medical device distribution.